RE:Recent consolidated short report decrease = Good news SV40 Sequence 'All Risk, No Reward'
The presence of the SV40 enhancer or promoter sequence in Pfizer monovalent and bivalent vaccines was first
discovered by microbiologist Mr. McKernan back in April 2023. Using
several methods to assess the nucleic acid composition of four vials of the Moderna and Pfizer vaccines, he determined that COVID-19 vaccines manufactured by Pfizer contained SV40 72bp enhancers and promoters.
Mr. McKernan said that because Pfizer's vaccines already contain an AmpR promoter similar to Moderna—which is used to drive the antibiotic resistance gene—the inclusion of the SV40 promoter was "completely redundant" and "all risk, no reward."
Mr. McKernan
said while the full 5kb SV40 virus was present in the polio vaccines, the presence of SV40 promoters was still concerning due to the risk of them integrating into the human genomes near oncogenes, which are genes that have the potential to cause cancer.
Angus Dalgleish, professor of oncology at St. George's Hospital Medical School in London, recently
wrote in The Conservative Woman about a higher incidence of cancers following COVID-19 vaccination seen by himself and his colleagues, including an “epidemic of explosive cancers” with multiple metastatic spread.
He noted the potential “DNA plasmid and SV40 integration in promoting cancer development.”